Catalyst
Slingshot members are tracking this event:
Phase 1/2 of Corcept's(CORT) Relacorilant plus Abraxane in Solid tumors (cancer) to be presented at ASCO
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CORT |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 03, 2019
Occurred Source:
https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.4130
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Relacorilant, Abraxane, Solid Tumor Cancer
